Abstract:Background: A new oral paracetamol formulation with the same paracetamol quantity (24 mg/mL) as a marketed formulation but with finer active ingredient particle size and lower amounts of maltitol (5.85 g/dose in the test formulation vs 7.25 g/dose in the reference formulation) and sorbitol (2.4 g/dose vs 2.83 g/dose) was developed. Objective: Establish the bioequivalence of the new pediatric formulation (test treatment) compared with the marketed formulation (reference treatment). Methods: This Phase I, open-label trial assigned healthy adult volunteers to a single 42-mL (1 g para-cetamol) dose of test or reference treatment. Participants received both treatments in a randomized order separated by a 72-hour washout period. The primary endpoints were AUC0-tlast (AUC vs time curve from time 0 to last measurable sampling timepoint), Cmax, and tmax. Safety assessments included adverse event, clinical laboratory, and physical examination data. Results: Thirty-five participants were randomized and treated. The study population was 42.9% women (57.1% men) with a median age of 30 years; most participants were non-Hispanic White. Mean Cmax values were comparable between test and reference products, with a median tmax of 1.00 hour for both. The test/reference ratios (%) (90% CI) for AUC0-tlast and Cmax were 98.69% (96.46, 100.97) and 100.73% (95.63, 106.10), respectively. There were no adverse events or deaths. Conclusions: The new paracetamol formulation is bioequivalent to the marketed formulation.

Relative bioavailability of paracetamol and amantadine hydrochloride compound capsules

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Relative bioavailability of disodium etidronate capsules in healthy volunteers

Studies on Bioequivalence of Indinavir Capsule in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetics of Compound Paracetamol Tablets ( Ⅱ ) in Healthy Volunteers

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Simultaneous Determination of Paracetamol and Amantadine in Human Plasma and Bioequivalence of Its Preparations in Healthy Volunteers by LC-MS

Relative bioavailability and bioequivalence of clopidogrel hydrogen sulfate tablets in healthy volunteers

HPLC-MS in Evaluating Bioequivalence of Two Kinds of Aniracetam Capsules in Healthy Volunteers

Study on Relative Bioavailability of Two Flunarizine Hydrochloride Capsules

Relative bioavailability of dipyridamole compound recipe extended-release capsules in healthy volunteers

Bioequivalence of a New Pediatric Paracetamol Oral Suspension Compared With a Marketed Formulation in Healthy Adults: A Randomized, Open-Label Study

Bioequivalence of Acetaminophen Plus Pseudoephedrine Hydrochloride Dispersible Tablets for Children in Healthy Volunteers

Bioequivalence of Pantoprazole Sodium Enteric-Coated Capsules in Human

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Relative Bioavailability of Ibuprofen Sustained-release Capsules in Human Subjects

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

Pharmacokinetic and Bioequivalence Evaluation of Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate, and Aspirin Tablets in Healthy Chinese Subjects in the Fasting and Postprandial Conditions

Study on Bioequivalence of Glucosamine Indometacin Enteric-coated Tablets in Healthy Volunteers